Schedule 13D ownership disclosure

BioLife Solutions Inc

Common Stock, $0.001 par value · CUSIP: 09062W204

Event date: 2025-04-07

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Casdin Capital, LLCReported CIK 0001534261

    Shares: 8,735,159.00 · Class: 18.5%

  • Casdin Partners Master Fund, L.P.

    Shares: 8,735,159.00 · Class: 18.5%

  • Casdin Partners GP, LLC

    Shares: 8,735,159.00 · Class: 18.5%

  • Eli Casdin

    Shares: 8,735,159.00 · Class: 18.5%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000919574-25-002364
Form type
SCHEDULE 13D/A
Filer
BIOLIFE SOLUTIONS INC
CIK
CIK 834365
Filed
Apr 09, 2025
Reporting period
Apr 07, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub